Quality of life outcomes in adults with moderate‐to‐severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

BACKGROUND: Psoriasis is a chronic inflammatory skin disease associated with quality of life (QoL) impairment. BRIDGE was a randomized, double‐blind, phase III study comparing the efficacy and safety of dimethylfumarate (DMF) with a fixed combination of fumaric acid esters (FAE) or placebo for the t...

Descripción completa

Detalles Bibliográficos
Autores principales: van de Kerkhof, P.C.M., Loewe, R., Mrowietz, U., Falques, M., Pau‐Charles, I., Szepietowski, J.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Psoriasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003897/
https://www.ncbi.nlm.nih.gov/pubmed/31465585
http://dx.doi.org/10.1111/jdv.15922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003897/
https://www.ncbi.nlm.nih.gov/pubmed/31465585
http://dx.doi.org/10.1111/jdv.15922

Ejemplares similares